|Venture Round, 11/2012 |
CIT GAP Funds
|Partial Close, 10/2013 ||$375k|
Lewis & Clark Pharmaceuticals Subsidiary, Inc. focuses on early stage pharmaceutical development for addressing the areas of arthritis, diabetes, glaucoma, and atherosclerosis. The company was incorporated in 2012 and is based in Charlottesville, Virginia.